Daniel Vapnek

Daniel Vapnek

Corporate Officer/Principal bij
University of California, Santa Barbara
87 jaar
Health Technology
Consumer Services

Profiel

Dr. Daniel Vapnek is an Advisor at Iguana Healthcare Management LLC.
He was Senior Vice president for Research at Amgen from 1981-1997.
During his tenure, scientists under his direction developed Epogen and Neupogen and discovered the RANK ligand which laid the groundwork for the development of denosumab for the treatment of osteoporosis.
For the past decade, Dr. Vapnek has been an advisor to venture capital funds and involved in several startups including BioArray solutions, which was recently sold to Immucor.
He is currently on The Board of Directors of Medicinova and an Adjunct Professor of Cellular and Molecular Biology at the University of California Santa Barbara.
Prior to joining Amgen, he was Professor of Molecular and Population Biology at the University of Georgia.
Dr. Vapnek received his undergraduate degree from the University of Miami (Florida) and a doctorate degree from the University of Miami (Florida).

Actieve functies van Daniel Vapnek

BedrijvenFunctieBegin
Corporate Officer/Principal -

Eerdere bekende functies van Daniel Vapnek

BedrijvenFunctieEinde
Directeur/Bestuurslid 01-04-2007
Protein Pathways, Inc.
Voorzitter 01-11-2004
ASPIRA WOMEN'S HEALTH INC. Directeur/Bestuurslid 01-05-2001
AMGEN INC. Hoofd Techniek/Wetenschap/O&O 31-12-1996
Corporate Officer/Principal -
Ervaring van Daniel Vapnek in detail bekijken

Opleiding van Daniel Vapnek

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

84

Eerstegraads connecties

9

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit9

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Protein Pathways, Inc.

  1. Beurs
  2. Insiders
  3. Daniel Vapnek